About 200 reports

Its products target the gastrointestinal, metabolic, genitourinary, musculoskeletal, inflammation, ophthalmic, neurology, and pulmonary therapeutic areas.

  • Diabetes
  • Hormone
  • Hospital
  • Therapy
  • Novo Nordisk Group

Headquartered in London, UK, the company engages in the discovery, development, and commercialization of prescription medicines for cardiovascular, gastrointestinal, neuroscience, infection, oncology, and respiratory and inflammatory diseases worldwide.

  • Hormone
  • Allergan plc
  • Bayer AG
  • Merck & Co., Inc.
  • Pfizer Inc.

pleurisy, pleural effusion, pneumonitis, pulmonary hypertension, and interstitial lung disease) Gastrointestinal (e. g., nausea, dyspepsia, and abdominal pain) Neuropsychiatric (e. g., seizure and psychosis) Hematologic (e. g., cytopenias such as leukopenia, lymphopenia, anemia, or thromboc

  • Hormone
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • MedImmune, LLC
  • Pfizer Inc.
  • Latest Clinical Trials News on Irritable Bowel Syndrome

Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials, E## Countries (%), 2015* Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials, E## Countries (%), 2015* Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trial

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Hormone
  • Pharmaceutical

Proportion of Non Alcoholic Fatty Liver Disease (NAFLD) to Gastrointestinal Clinical Trials, E## Countries (%), 2015* Proportion of Non Alcoholic Fatty Liver Disease (NAFLD) to Gastrointestinal Clinical Trials, E## Countries (%), 2015* Proportion of Non Alcoholic Fatty Liver Disease

  • Hormone
  • World
  • AstraZeneca PLC
  • Galmed International Ltd.
  • Intercept Pharmaceuticals, Inc.

It is active in therapeutic areas of Central Nervous System (CNS), Cardiovascular (CV), gastrointestinal, diabetology, anti-infective and pain management segments.

  • Hormone
  • Biocon Limited
  • Hospira, Inc.
  • Mylan Inc.
  • Sandoz Inc.

Systemic tetracycline may cause gastrointestinal upset, nausea, diarrhea, and vaginal yeast infection.

  • Antifungal
  • Autoimmune Disease
  • Dermatological Condition
  • Hormone
  • Pharmaceutical

These areas include some of the world' s most serious illnesses and together represent a major worldwide burden of disease: cancer, cardiovascular, gastrointestinal, infection, neuroscience and respiratory & inflammation.

  • Hormone
  • China
  • AstraZeneca Pharmaceutical Co., Ltd
  • Bristol-Myers Squibb Company
  • Zhejiang Xianju Pharmaceutical Co., Ltd
  • and Forecasts (Billion Yuan)

ALTERNATIVELY, ANTAGONISM OF ##-HT## - A RECEPTOR THAT IS INVOLVED IN THE REGULATION OF NAUSEA, VOMITING, AND THE GASTROINTESTINAL TRACT - COULD COUNTERACT THE Serotonin Modulators and Stimulators Chapter IV DEPRESSION TREATMENT DRUGS SALES VOLUMES AND FORECASTS UNDESIRABLE INCREASE IN ACTIVA

  • Antidepressant
  • Hormone
  • Therapy
  • China
  • Demand

These areas include some of the world' s most serious illnesses and together represent a major worldwide burden of disease: cancer, cardiovascular, gastrointestinal, infection, neuroscience and respiratory & inflammation.

  • Hormone
  • China
  • AstraZeneca Pharmaceutical Co., Ltd
  • Bristol-Myers Squibb Company
  • Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
  • Benazepril is prescribed off-label in both dogs and cats to treat CHF.

NSAIDS are associated with gastrointestinal ulcers/ perforations, and kidney and liver toxicity.

  • Hormone
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Merial Limited
  • Zoetis Inc.

The company produces and markets high-quality products and biologics in the areas of gastrointestinal disease, neurology, psychiatry, immunology, pain control, infectious disease, and oncology.

  • Hormone
  • China
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Beijing Novartis Pharma Ltd

This enables the drug to bypass the gastrointestinal tract.

  • Hormone
  • AbbVie Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Pfizer Inc.

The company produces and markets high-quality products and biologics in the areas of gastrointestinal disease, neurology, psychiatry, immunology, pain control, infectious disease, and oncology.

  • Hormone
  • China
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group
  • Shenzhen Main Luck Pharmaceuticals Inc.
  • J&J'S PROSTATE CANCER PORTFOLIO ASSESSMENT, 2014

gastrointestinal stromal tumors).

  • Hormone
  • Prostate Cancer
  • Astellas Pharma Inc.
  • Bayer AG
  • PROVENGE group
  • 7.10.7. KEY CLINICAL TRIAL RESULTS
  • MYCAPSSA™ / OCTREOLIN™ / ORAL OCTREOTIDE: CURRENT STATUS OF DEVELOPMENT

THIS IS DONE TO DECREASE THE PROBABILITY OF GASTROINTESTINAL SYMPTOMS.

  • Endocrine Disease
  • Hormone
  • United States
  • LipimetiX Development LLC
  • Novartis AG
  • NEW DEVELOPMENTS IN HORMONE DRUG DELIVERY

By avoiding the gastrointestinal system, the drug is less likely to cause nausea.

  • Hormone
  • Generex Biotechnology Corporation
  • Nitto Denko Corporation
  • Noven Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Clinical Trial profile. 31 Trial Title
  • Clinical Trial profile. 41 Trial Title

PROPORTION OF HEPATORENAL SYNDROME TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* PROPORTION OF HEPATORENAL SYNDROME TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* PROPORTION OF HEPATORENAL SYNDROME TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTR

  • Digestive System Disorder
  • Hormone
  • World
  • Product Initiative
  • Mallinckrodt plc

Cardiovascular Drugs Respiratory Drugs Anti-cancer Drugs CNS Drugs The Others segment includes dermatology, genitourinary, gastrointestinal, and endocrine drugs.

  • Anti-Infective
  • Hormone
  • Japan
  • Meiji Seika Pharma Co., Ltd.
  • Nipro Corporation

References P##(SHC) Therapeutic Area/ Disease Indications Diabetes Gastrointestinal lesions University of Bari Aldo Moro, Italy.

  • Hormone
  • United States
  • MC2 Biotek Group
  • POXEL SA
  • XOMA Corporation
  • CLINICAL TRIAL PROFILE SNAPSHOTS

PROPORTION OF DIABETIC GASTROPARESIS TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* PROPORTION OF DIABETIC GASTROPARESIS TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* As of July 2017, there were ## clinical trials in Phase II, of which two clinical tria

  • Chronic Disease
  • Hormone
  • World
  • Product Initiative
  • Allergan plc
  • CLINICAL TRIAL PROFILE SNAPSHOTS

PROPORTION OF HEPATIC INJURY TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* PROPORTION OF HEPATIC INJURY TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* PROPORTION OF HEPATIC INJURY TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* Cou

  • Clinical Trial
  • Drug Discovery And Development
  • Hormone
  • World
  • Product Initiative
  • CLINICAL TRIAL PROFILE SNAPSHOTS
  • Clinical Trial profile. 11 Trial Title

PROPORTION OF ESOPHAGEAL VARICES TO GASTROINTESTINAL CLINICAL TRIALS, G## COUNTRIES (%), 2017* PROPORTION OF ESOPHAGEAL VARICES TO GASTROINTESTINAL CLINICAL TRIALS, G## COUNTRIES (%), 2017* PROPORTION OF ESOPHAGEAL VARICES TO GASTROINTESTINAL CLINICAL TRIALS, G## COUNTRIES (%

  • Digestive System Disorder
  • Hormone
  • Therapy
  • World
  • Product Initiative
  • Clinical Trial profile. 21 Trial Title

PROPORTION OF DYSPHAGIA TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* PROPORTION OF DYSPHAGIA TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* PROPORTION OF DYSPHAGIA TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* Country Name Numbe

  • Clinical Trial
  • Hormone
  • World
  • Product Initiative
  • Celgene Corporation
  • Clinical Trial profile. 76 Trial Title
  • Target

PROPORTION OF ASCITES TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* PROPORTION OF ASCITES TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* PROPORTION OF ASCITES TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* Country Name Number of C

  • Clinical Trial
  • Hormone
  • Therapy
  • World
  • Product Initiative

IT ALSO COMES WITH A WARNING REGARDING GASTROINTESTINAL (GI) SYMPTOMS, INCLUDING NAUSEA, VOMITING, AND DIARRHEA, AS WELL AS RENAL FAILURE, AND IS NOT RECOMMENDED FOR USE IN PATIENTS WITH IMPAIRED HEPATIC FUNCTION (JEVTANA PACKAGE INSERT, 2014).

  • Hormone
  • World
  • Astellas Pharma Inc.
  • OncoGenex Pharmaceuticals, Inc.
  • PROVENGE group

IT ALSO COMES WITH A WARNING REGARDING GASTROINTESTINAL (GI) SYMPTOMS, INCLUDING NAUSEA, VOMITING, AND DIARRHEA, AS WELL AS RENAL FAILURE, AND IS NOT RECOMMENDED FOR USE IN PATIENTS WITH IMPAIRED HEPATIC FUNCTION (JEVTANA PACKAGE INSERT, 2014).

  • Hormone
  • World
  • Astellas Pharma Inc.
  • OncoGenex Pharmaceuticals, Inc.
  • PROVENGE group
  • Clinical Trial profile. 25 Trial Title
  • Clinical Trial profile. 8 Trial Title

PROPORTION OF ALCOHOLIC HEPATITIS TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* PROPORTION OF ALCOHOLIC HEPATITIS TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* PROPORTION OF ALCOHOLIC HEPATITIS TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES

  • Digestive System Disorder
  • Hormone
  • World
  • Product Initiative
  • Conatus Pharmaceuticals Inc.
  • Clinical Trial profile. 60 Trial Title
  • Clinical Trial profile. 43 Trial Title

PROPORTION OF EOSINOPHILIC ESOPHAGITIS TO GASTROINTESTINAL CLINICAL TRIALS, G## COUNTRIES (%), 2017* PROPORTION OF EOSINOPHILIC ESOPHAGITIS TO GASTROINTESTINAL CLINICAL TRIALS, G## COUNTRIES (%), 2017* PROPORTION OF EOSINOPHILIC ESOPHAGITIS TO GASTROINTESTINAL CLINICAL TRIAL

  • Digestive System Disorder
  • Healthcare
  • Hormone
  • World
  • Product Initiative
  • Official Title
  • Target

About Velusetrag Velusetrag is an oral, once-daily investigational medicine discovered internally and developed for gastrointestinal motility disorders.

  • Clinical Trial
  • Diabetes
  • Hormone
  • World
  • Product Initiative